Hypopharyngeal Cancer

Our multidisciplinary team has extensive experience in diagnosing and treating hypopharyngeal cancer, which develops in the hypopharynx, the bottom part of the throat. Our surgeons, medical oncologists, and radiation oncologists collaborate to create a treatment plan based on the location of the tumor, its size, and how far it has spread. The goal is to find the right combination of treatments to destroy hypopharyngeal cancer while preserving organ function.

Clinical Trials and Research Studies

Phase 1

A Phase 1 Open-Label Multicenter Study to Assess the Safety Tolerability and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors

Learn More

Phase 1

A Phase 1 Open-Label Dose-Escalation and Cohort Expansion First-in-Human Study of the Safety Tolerability Activity and Pharmacokinetics of REGN3767 (anti-LAG-3 mAb) Administered Alone or in Combination with REGN2810 (anti-PD-1 mAb) in Patients with Ad

Learn More